Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 2
1(50.0%)
2Total
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05794841Unknown

Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract

Role: collaborator

NCT04225364Phase 2Completed

Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma

Role: collaborator

NCT04210934Completed

Study of Microbiota in Longevity County, Yongfu

Role: collaborator

NCT04044118Not ApplicableCompleted

Calorie Restriction Intervention Induces Enterotype-associated BMI Loss in Nonobese Individuals

Role: lead

All 4 trials loaded